In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Latest
Estée Lauder brings science to shade matching
The collaboration could help the company improve shade accuracy, develop more natural, consistent formulas, and enhance inclusivity across its luxury beauty portfolio.
CRN initiative expands nutrition access in Missouri
Stratum Nutrition is contributing 10,000 bottles of multivitamins through Vitaquest’s VQ Cares program.
Vitamin Angels steps up support for Indonesia’s vitamin A program
The nonprofit is directly supporting Indonesia’s nationwide vitamin A campaign for the first time after more than a decade of work in the country.